News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Boxer Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/16/2023 |
SC 13D/A
| Boxer Capital, LLC reports a 15.9% stake in Mirati Therapeutics, Inc. |
| 11/08/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/15/2022 |
SC 13D/A
| Boxer Capital, LLC reports a 15.1% stake in Tyra Biosciences, Inc. |
| 05/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/26/2021 |
SC 13D/A
| Boxer Capital, LLC reports a 10.9% stake in Odonate Therapeutics, Inc. |
| 11/22/2021 |
SC 13D/A
| Boxer Capital, LLC reports a 12% stake in Odonate Therapeutics, Inc. |
| 10/30/2020 |
SC 13D/A
| Boxer Capital, LLC reports a 18.9% stake in Mirati Therapeutics, Inc. |
| 09/01/2020 |
SC 13D/A
| Boxer Capital, LLC reports a 12.6% stake in Odonate Therapeutics, Inc. |
| 02/14/2020 |
SC 13D/A
| Boxer Capital, LLC reports a 18.7% stake in Mirati Therapeutics, Inc. |
| 07/19/2019 |
SC 13D/A
| Boxer Capital, LLC reports a 18.6% stake in Mirati Therapeutics, Inc. |
| 12/27/2018 |
SC 13D/A
| Boxer Capital, LLC reports a 11.1% stake in Odonate Therapeutics, Inc. |
| 11/20/2017 |
SC 13D/A
| Boxer Capital, LLC reports a 16.9% stake in Mirati Therapeutics, Inc. |
| 06/27/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/30/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 01/10/2017 |
SC 13D/A
| Mirati Therapeutics, Inc. reports a 16.6% stake in Mirati Therapeutics, Inc. |
| 09/28/2016 |
SC 13D/A
| Mirati Therapeutics, Inc. reports a 14.5% stake in Mirati Therapeutics, Inc. |
| 06/24/2016 |
SC 13D/A
| Mirati Therapeutics, Inc. reports a 14.5% stake in Mirati Therapeutics, Inc. |
| 06/08/2016 |
SC 13D/A
| Mirati Therapeutics, Inc. reports a 14.5% stake in Mirati Therapeutics, Inc. |
| 03/17/2016 |
SC 13D/A
| Mirati Therapeutics, Inc. reports a 12.6% stake in Mirati Therapeutics, Inc. |
| 08/24/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 08/26/2010 |
SC 13D/A
| Boxer Capital, LLC has filed a Schedule 13D for AMARIN CORPORATION PLC |
| 06/29/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
|
|